Verici Dx plc (LON:VRCI – Get Free Report) shares shot up 14% on Friday . The company traded as high as GBX 2.93 ($0.04) and last traded at GBX 2.85 ($0.04). Approximately 1,706,122 shares traded hands during trading, an increase of 75% from the average session volume of 975,578 shares. The stock had previously closed at GBX 2.50 ($0.03).
Verici Dx Price Performance
The stock has a market capitalization of £7.59 million, a P/E ratio of -1.45 and a beta of 1.59. The company has a debt-to-equity ratio of 4.64, a current ratio of 4.54 and a quick ratio of 8.49. The company’s 50-day simple moving average is GBX 3.16 and its 200-day simple moving average is GBX 3.86.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- Utilities Stocks Explained – How and Why to Invest in Utilities
- MarketBeat Week in Review – 03/24 – 03/28
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- 5 Top Rated Dividend Stocks to Consider
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
